Cargando…

Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer

BACKGROUND: The screening biomarkers for early detection of colorectal cancer (CRC) is lacking. The aim is to identify epigenetic silenced genes and clarify its roles and underlying mechanism in CRC. We conducted integrative analyses of epigenome-wide Human Methylation 450 K arrays and transcriptome...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Zixu, Yu, Xihu, Chen, Wenle, Chen, Daici, Cai, Jian, Jiang, Yingming, Liu, Xiaoxia, Wu, Zhijie, Wang, Lei, Grady, William M., Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308366/
https://www.ncbi.nlm.nih.gov/pubmed/35870943
http://dx.doi.org/10.1186/s12964-022-00878-4
_version_ 1784752969915301888
author Yuan, Zixu
Yu, Xihu
Chen, Wenle
Chen, Daici
Cai, Jian
Jiang, Yingming
Liu, Xiaoxia
Wu, Zhijie
Wang, Lei
Grady, William M.
Wang, Hui
author_facet Yuan, Zixu
Yu, Xihu
Chen, Wenle
Chen, Daici
Cai, Jian
Jiang, Yingming
Liu, Xiaoxia
Wu, Zhijie
Wang, Lei
Grady, William M.
Wang, Hui
author_sort Yuan, Zixu
collection PubMed
description BACKGROUND: The screening biomarkers for early detection of colorectal cancer (CRC) is lacking. The aim is to identify epigenetic silenced genes and clarify its roles and underlying mechanism in CRC. We conducted integrative analyses of epigenome-wide Human Methylation 450 K arrays and transcriptome to screen out candidate epigenetic driver genes with transcription silencing. Methylated silencing HAND2 were identified and verified in large CRC cohort. The mechanism of HAND2 expression by promoter inhibition were clarified both in vitro and vivo assays. Cell biofunctional roles of HAND2 methylation was investigated in CRC cells. HAND2 reconstitution were constructed by lentivirus plasmid and tumor xenograft model of HAND2 were built subcutaneously. Genomic mRNA analysis by RNA-sequencing and subsequent GSEA analysis were performed to identify potential target of HAND2 and qPCR/WB was conducted to identify the results. RESULTS: We firstly reported high frequency of HAND2 methylation in promoter in CRC and hypermethylation was negatively correlated with expression silencing and leaded to poor survival in several CRC cohort patients. 5-Aza treatment to demethylated HAND2 could revert its expression in CRC cells. Functionally, HAND2 reconstitution can inhibit cell proliferation, invasion and migration in vitro. In tumor xenograft, HAND2 reconstruction significantly repressed tumor growth when compared to control vector. Thousands of aberrant expressed genes were observed in the heatmap of RNA-sequencing data. HAND2 reconstitution could bind to ERK and reduce its phosphorylation by CoIP assay. These above results showed HAND2 reconstitution perturbed the activation of MAPK/ERK signaling by reduction of ERK phosphorylation. CONCLUSIONS: HAND2 is one tumor suppressor by targeting ERK signaling and one potential epigenetic driver gene in CRC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-022-00878-4.
format Online
Article
Text
id pubmed-9308366
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93083662022-07-24 Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer Yuan, Zixu Yu, Xihu Chen, Wenle Chen, Daici Cai, Jian Jiang, Yingming Liu, Xiaoxia Wu, Zhijie Wang, Lei Grady, William M. Wang, Hui Cell Commun Signal Research BACKGROUND: The screening biomarkers for early detection of colorectal cancer (CRC) is lacking. The aim is to identify epigenetic silenced genes and clarify its roles and underlying mechanism in CRC. We conducted integrative analyses of epigenome-wide Human Methylation 450 K arrays and transcriptome to screen out candidate epigenetic driver genes with transcription silencing. Methylated silencing HAND2 were identified and verified in large CRC cohort. The mechanism of HAND2 expression by promoter inhibition were clarified both in vitro and vivo assays. Cell biofunctional roles of HAND2 methylation was investigated in CRC cells. HAND2 reconstitution were constructed by lentivirus plasmid and tumor xenograft model of HAND2 were built subcutaneously. Genomic mRNA analysis by RNA-sequencing and subsequent GSEA analysis were performed to identify potential target of HAND2 and qPCR/WB was conducted to identify the results. RESULTS: We firstly reported high frequency of HAND2 methylation in promoter in CRC and hypermethylation was negatively correlated with expression silencing and leaded to poor survival in several CRC cohort patients. 5-Aza treatment to demethylated HAND2 could revert its expression in CRC cells. Functionally, HAND2 reconstitution can inhibit cell proliferation, invasion and migration in vitro. In tumor xenograft, HAND2 reconstruction significantly repressed tumor growth when compared to control vector. Thousands of aberrant expressed genes were observed in the heatmap of RNA-sequencing data. HAND2 reconstitution could bind to ERK and reduce its phosphorylation by CoIP assay. These above results showed HAND2 reconstitution perturbed the activation of MAPK/ERK signaling by reduction of ERK phosphorylation. CONCLUSIONS: HAND2 is one tumor suppressor by targeting ERK signaling and one potential epigenetic driver gene in CRC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-022-00878-4. BioMed Central 2022-07-23 /pmc/articles/PMC9308366/ /pubmed/35870943 http://dx.doi.org/10.1186/s12964-022-00878-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yuan, Zixu
Yu, Xihu
Chen, Wenle
Chen, Daici
Cai, Jian
Jiang, Yingming
Liu, Xiaoxia
Wu, Zhijie
Wang, Lei
Grady, William M.
Wang, Hui
Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer
title Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer
title_full Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer
title_fullStr Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer
title_full_unstemmed Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer
title_short Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer
title_sort epigenetic silencing and tumor suppressor gene of hand2 by targeting erk signaling in colorectal cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308366/
https://www.ncbi.nlm.nih.gov/pubmed/35870943
http://dx.doi.org/10.1186/s12964-022-00878-4
work_keys_str_mv AT yuanzixu epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer
AT yuxihu epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer
AT chenwenle epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer
AT chendaici epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer
AT caijian epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer
AT jiangyingming epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer
AT liuxiaoxia epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer
AT wuzhijie epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer
AT wanglei epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer
AT gradywilliamm epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer
AT wanghui epigeneticsilencingandtumorsuppressorgeneofhand2bytargetingerksignalingincolorectalcancer